About
La Force
La Force is our decision to become actors rather than spectators in this terrible story. It is choosing action… and hope.
Our
story
Turning tragedy into positive action
It all began when Marie-Catherine noticed that Anakin didn’t run, jump or climb stairs like other children his age. Like any worried parent, she started researching motor skill problems in children. Although she was convinced it was Duchenne, she hoped she was wrong. Unfortunately, she wasn’t. In October 2013, Anakin, then 5 years old, received his diagnosis.
“You hope it will be a disease that can be cured, because with Duchenne muscular dystrophy, there is no option. There is nothing in front of you to treat it.” (Marie-Catherine Du Berger)
Once the shock of the news had settled, Marie-Catherine and her partner decided not to give up. “Instead of feeling sorry for ourselves and staying sad and angry, we decided to move forward and get something positive out of all this, even though it was catastrophic,” she says.
Their resilience and determination led to the founding of La Force DMD in 2014, a non-profit organization run entirely by volunteers. Its mission: to raise awareness of the disease in communities across Quebec and the rest of Canada, and to bring families together around a common goal, access to treatments.
In its early years, La Force DMD helped fund two Quebec research projects on Duchenne muscular dystrophy. It also made patients’ voices heard in the debates on access to treatments, notably regarding the approval of ataluren, and attended the FDA advisory committee hearing in 2017.
Today, its activities focus on awareness and on representing patients and their families. With partners, La Force DMD meets with drug evaluation and reimbursement bodies (CDA-AMC, INESSS, pCPA) to make sure families’ lived experience is taken into account. When the first DMD-specific treatment was approved in Canada in October 2025, the work was not over: now families need to be able to access it.
There is hope, and also a lot of work to do.

That is why we need your support.
From parent to parent, from human to human, we invite you to join our movement.

Our mission
Unity is strength
For the first time in the history of Duchenne muscular dystrophy (DMD), there is hope on the horizon. In October 2025, Health Canada approved the first DMD-specific treatment in Canada. Other therapies are already available elsewhere in the world, and new treatments are being developed and evaluated.
But an approved treatment is only useful if it is accessible. Families still face delays, reimbursement decisions and access difficulties.
La Force DMD’s mission is to bring the DMD community together around a common goal: fast and equitable access to treatments. To get there, we raise public awareness, inform and equip families, and carry their voices to evaluation bodies, public drug plans and decision-makers, in collaboration with our partners in Quebec and across Canada.
When it comes to access to treatments for rare diseases, it is essential that our community is strong: each of its members can become an active spokesperson who helps raise awareness of Duchenne muscular dystrophy among the general public, as well as the challenges of access to treatments.
Our mandate
Our mandate is to inform and equip families affected by Duchenne muscular dystrophy (DMD) so they can make their voices heard and advocate for equitable access to treatments. We also represent them before evaluation bodies, public drug plans and decision-makers.
We believe that every action matters in the pursuit of a cure and that unity is strength.


Our
objectives
Our ultimate goal is to help improve the lives of an entire generation of boys and girls:
- By building ties within the DMD community and raising its profile;
- By carrying the voice of patients and their families to drug evaluation bodies, public drug plans and the various levels of government;
- By working tirelessly to speed up and expand access to approved treatments and those on the way;
- By closely following advances in DMD research and sharing them with families.
Among the means we use to achieve these objectives:
- Developing communication and information tools, including this website, a blog and a newsletter.
- Developing and maintaining contacts with organizations that share our goals in Canada, the United States and elsewhere.
- Taking part, with our partners, in consultations and surveys that bring families’ lived experience forward.
- Raising public awareness, notably through events, publications and campaigns.
